Implantable cardioverter-defibrillator therapy in the absence of significant symptoms : rhythm diagnosis and management aided by stored electrogram analysis

This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms before implantable cardioverter-defibrillator (ICD) therapy. The study population included 48 patients who received the Cadence Tiered Therapy De...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 1993-06, Vol.87 (6), p.1897-1906
Hauptverfasser: HOOK, B. G, CELLANS, D. J, KLEIMAN, R. B, FLORES, B. T, MARCHLINSKI, F. E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1906
container_issue 6
container_start_page 1897
container_title Circulation (New York, N.Y.)
container_volume 87
creator HOOK, B. G
CELLANS, D. J
KLEIMAN, R. B
FLORES, B. T
MARCHLINSKI, F. E
description This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms before implantable cardioverter-defibrillator (ICD) therapy. The study population included 48 patients who received the Cadence Tiered Therapy Defibrillator System, an investigational third-generation ICD with ventricular electrogram storage capabilities. Criteria for arrhythmia diagnosis were based on analysis of the electrogram rate, RR interval variability, and morphology. Twenty-nine of the 48 patients (60%) experienced at least one episode of antitachycardia pacing or shock (one shock or more in 25 of 29 patients) that was preceded by minimal or no symptoms during a mean follow-up of 15.1 +/- 7.8 months. There were 194 tachycardia episodes registered by the device, including 101 for which ventricular electrograms were stored and available for analysis. Of the 101 stored electrograms, 74 were classified as ventricular tachycardia (VT), 24 as non-VT rhythms (atrial fibrillation, 13; supraventricular tachycardia, six; rate-sensing lead disruption, four; T wave oversensing, one), and only three as indeterminate rhythms. Based on the electrogram analysis, changes in tachycardia detection criteria and/or antiarrhythmic drug regimens were implemented and were associated with a reduction in the number of device responses for non-VT rhythms from 24 during the initial study period to three during 11.0 +/- 7.2 months of additional follow-up. ICD responses in the absence of symptoms are relatively common in third-generation devices with antitachycardia pacing capabilities. Despite potential limitations such as the effect of bundle branch block on the electrogram morphology during supraventricular tachycardia, the availability of electrogram storage capabilities allowed a presumptive diagnosis of the events precipitating asymptomatic device responses. Device reprogramming based on analysis of stored electrograms was associated with a dramatic reduction in the incidence of ICD responses for non-VT rhythms.
doi_str_mv 10.1161/01.CIR.87.6.1897
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75761258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75761258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-626d4110ea22694fa9fb7405e6e045ec524a33dc1dd7fbe8486b08cdd23f63793</originalsourceid><addsrcrecordid>eNo9kU-LFDEQxYMo6-zq3YuQg3jrNn-602lvMqg7sCCInkN1UpmJdLrbpGehv4sf1gw77KmqqN97UPUIecdZzbninxiv94efte5qVXPddy_IjreiqZpW9i_JjjHWV50U4jW5zflPGZXs2htyo1vWtEzsyL9DXEaYVhhGpBaSC_MjphVT5dCHIYVxhHVOdD1hgmWjYbq0FIaMk0U6e5rDcQo-2GJC8xaXdY6ZfqbptK2nSF2A4zTnkClMjkaY4IgRCwrBoaPDRnOxLx2OaNc0HxPEgsK4Fc0b8srDmPHttd6R39--_trfVw8_vh_2Xx4q2zC1Vkoo13DOEIRQfeOh90PXsBYVlivRloeAlM5y5zo_oG60Gpi2zgnpyz96eUc-Pvkuaf57xryaGLLFcvqE8zmbru0UF60uIHsCbZpzTujNkkKEtBnOzCUQw7gpgRjdGWUugRTJ-6v3eYjongXXBMr-w3UP2cLoE0w25Ges0VL3msv_N-KXfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75761258</pqid></control><display><type>article</type><title>Implantable cardioverter-defibrillator therapy in the absence of significant symptoms : rhythm diagnosis and management aided by stored electrogram analysis</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>HOOK, B. G ; CELLANS, D. J ; KLEIMAN, R. B ; FLORES, B. T ; MARCHLINSKI, F. E</creator><creatorcontrib>HOOK, B. G ; CELLANS, D. J ; KLEIMAN, R. B ; FLORES, B. T ; MARCHLINSKI, F. E</creatorcontrib><description>This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms before implantable cardioverter-defibrillator (ICD) therapy. The study population included 48 patients who received the Cadence Tiered Therapy Defibrillator System, an investigational third-generation ICD with ventricular electrogram storage capabilities. Criteria for arrhythmia diagnosis were based on analysis of the electrogram rate, RR interval variability, and morphology. Twenty-nine of the 48 patients (60%) experienced at least one episode of antitachycardia pacing or shock (one shock or more in 25 of 29 patients) that was preceded by minimal or no symptoms during a mean follow-up of 15.1 +/- 7.8 months. There were 194 tachycardia episodes registered by the device, including 101 for which ventricular electrograms were stored and available for analysis. Of the 101 stored electrograms, 74 were classified as ventricular tachycardia (VT), 24 as non-VT rhythms (atrial fibrillation, 13; supraventricular tachycardia, six; rate-sensing lead disruption, four; T wave oversensing, one), and only three as indeterminate rhythms. Based on the electrogram analysis, changes in tachycardia detection criteria and/or antiarrhythmic drug regimens were implemented and were associated with a reduction in the number of device responses for non-VT rhythms from 24 during the initial study period to three during 11.0 +/- 7.2 months of additional follow-up. ICD responses in the absence of symptoms are relatively common in third-generation devices with antitachycardia pacing capabilities. Despite potential limitations such as the effect of bundle branch block on the electrogram morphology during supraventricular tachycardia, the availability of electrogram storage capabilities allowed a presumptive diagnosis of the events precipitating asymptomatic device responses. Device reprogramming based on analysis of stored electrograms was associated with a dramatic reduction in the incidence of ICD responses for non-VT rhythms.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.CIR.87.6.1897</identifier><identifier>PMID: 8504502</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Atrial Fibrillation - diagnosis ; Atrial Fibrillation - epidemiology ; Biological and medical sciences ; Cardiac dysrhythmias ; Cardiology. Vascular system ; Defibrillators, Implantable ; Electrocardiography ; Equipment Design ; Female ; Follow-Up Studies ; Heart ; Humans ; Male ; Medical sciences ; Middle Aged ; Signal Processing, Computer-Assisted ; Tachycardia, Supraventricular - diagnosis ; Tachycardia, Supraventricular - epidemiology ; Tachycardia, Ventricular - diagnosis ; Tachycardia, Ventricular - epidemiology ; Tachycardia, Ventricular - therapy ; Time Factors</subject><ispartof>Circulation (New York, N.Y.), 1993-06, Vol.87 (6), p.1897-1906</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-626d4110ea22694fa9fb7405e6e045ec524a33dc1dd7fbe8486b08cdd23f63793</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4838981$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8504502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HOOK, B. G</creatorcontrib><creatorcontrib>CELLANS, D. J</creatorcontrib><creatorcontrib>KLEIMAN, R. B</creatorcontrib><creatorcontrib>FLORES, B. T</creatorcontrib><creatorcontrib>MARCHLINSKI, F. E</creatorcontrib><title>Implantable cardioverter-defibrillator therapy in the absence of significant symptoms : rhythm diagnosis and management aided by stored electrogram analysis</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms before implantable cardioverter-defibrillator (ICD) therapy. The study population included 48 patients who received the Cadence Tiered Therapy Defibrillator System, an investigational third-generation ICD with ventricular electrogram storage capabilities. Criteria for arrhythmia diagnosis were based on analysis of the electrogram rate, RR interval variability, and morphology. Twenty-nine of the 48 patients (60%) experienced at least one episode of antitachycardia pacing or shock (one shock or more in 25 of 29 patients) that was preceded by minimal or no symptoms during a mean follow-up of 15.1 +/- 7.8 months. There were 194 tachycardia episodes registered by the device, including 101 for which ventricular electrograms were stored and available for analysis. Of the 101 stored electrograms, 74 were classified as ventricular tachycardia (VT), 24 as non-VT rhythms (atrial fibrillation, 13; supraventricular tachycardia, six; rate-sensing lead disruption, four; T wave oversensing, one), and only three as indeterminate rhythms. Based on the electrogram analysis, changes in tachycardia detection criteria and/or antiarrhythmic drug regimens were implemented and were associated with a reduction in the number of device responses for non-VT rhythms from 24 during the initial study period to three during 11.0 +/- 7.2 months of additional follow-up. ICD responses in the absence of symptoms are relatively common in third-generation devices with antitachycardia pacing capabilities. Despite potential limitations such as the effect of bundle branch block on the electrogram morphology during supraventricular tachycardia, the availability of electrogram storage capabilities allowed a presumptive diagnosis of the events precipitating asymptomatic device responses. Device reprogramming based on analysis of stored electrograms was associated with a dramatic reduction in the incidence of ICD responses for non-VT rhythms.</description><subject>Atrial Fibrillation - diagnosis</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Biological and medical sciences</subject><subject>Cardiac dysrhythmias</subject><subject>Cardiology. Vascular system</subject><subject>Defibrillators, Implantable</subject><subject>Electrocardiography</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Signal Processing, Computer-Assisted</subject><subject>Tachycardia, Supraventricular - diagnosis</subject><subject>Tachycardia, Supraventricular - epidemiology</subject><subject>Tachycardia, Ventricular - diagnosis</subject><subject>Tachycardia, Ventricular - epidemiology</subject><subject>Tachycardia, Ventricular - therapy</subject><subject>Time Factors</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kU-LFDEQxYMo6-zq3YuQg3jrNn-602lvMqg7sCCInkN1UpmJdLrbpGehv4sf1gw77KmqqN97UPUIecdZzbninxiv94efte5qVXPddy_IjreiqZpW9i_JjjHWV50U4jW5zflPGZXs2htyo1vWtEzsyL9DXEaYVhhGpBaSC_MjphVT5dCHIYVxhHVOdD1hgmWjYbq0FIaMk0U6e5rDcQo-2GJC8xaXdY6ZfqbptK2nSF2A4zTnkClMjkaY4IgRCwrBoaPDRnOxLx2OaNc0HxPEgsK4Fc0b8srDmPHttd6R39--_trfVw8_vh_2Xx4q2zC1Vkoo13DOEIRQfeOh90PXsBYVlivRloeAlM5y5zo_oG60Gpi2zgnpyz96eUc-Pvkuaf57xryaGLLFcvqE8zmbru0UF60uIHsCbZpzTujNkkKEtBnOzCUQw7gpgRjdGWUugRTJ-6v3eYjongXXBMr-w3UP2cLoE0w25Ges0VL3msv_N-KXfA</recordid><startdate>19930601</startdate><enddate>19930601</enddate><creator>HOOK, B. G</creator><creator>CELLANS, D. J</creator><creator>KLEIMAN, R. B</creator><creator>FLORES, B. T</creator><creator>MARCHLINSKI, F. E</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930601</creationdate><title>Implantable cardioverter-defibrillator therapy in the absence of significant symptoms : rhythm diagnosis and management aided by stored electrogram analysis</title><author>HOOK, B. G ; CELLANS, D. J ; KLEIMAN, R. B ; FLORES, B. T ; MARCHLINSKI, F. E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-626d4110ea22694fa9fb7405e6e045ec524a33dc1dd7fbe8486b08cdd23f63793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Atrial Fibrillation - diagnosis</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Biological and medical sciences</topic><topic>Cardiac dysrhythmias</topic><topic>Cardiology. Vascular system</topic><topic>Defibrillators, Implantable</topic><topic>Electrocardiography</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Signal Processing, Computer-Assisted</topic><topic>Tachycardia, Supraventricular - diagnosis</topic><topic>Tachycardia, Supraventricular - epidemiology</topic><topic>Tachycardia, Ventricular - diagnosis</topic><topic>Tachycardia, Ventricular - epidemiology</topic><topic>Tachycardia, Ventricular - therapy</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HOOK, B. G</creatorcontrib><creatorcontrib>CELLANS, D. J</creatorcontrib><creatorcontrib>KLEIMAN, R. B</creatorcontrib><creatorcontrib>FLORES, B. T</creatorcontrib><creatorcontrib>MARCHLINSKI, F. E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HOOK, B. G</au><au>CELLANS, D. J</au><au>KLEIMAN, R. B</au><au>FLORES, B. T</au><au>MARCHLINSKI, F. E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implantable cardioverter-defibrillator therapy in the absence of significant symptoms : rhythm diagnosis and management aided by stored electrogram analysis</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>1993-06-01</date><risdate>1993</risdate><volume>87</volume><issue>6</issue><spage>1897</spage><epage>1906</epage><pages>1897-1906</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms before implantable cardioverter-defibrillator (ICD) therapy. The study population included 48 patients who received the Cadence Tiered Therapy Defibrillator System, an investigational third-generation ICD with ventricular electrogram storage capabilities. Criteria for arrhythmia diagnosis were based on analysis of the electrogram rate, RR interval variability, and morphology. Twenty-nine of the 48 patients (60%) experienced at least one episode of antitachycardia pacing or shock (one shock or more in 25 of 29 patients) that was preceded by minimal or no symptoms during a mean follow-up of 15.1 +/- 7.8 months. There were 194 tachycardia episodes registered by the device, including 101 for which ventricular electrograms were stored and available for analysis. Of the 101 stored electrograms, 74 were classified as ventricular tachycardia (VT), 24 as non-VT rhythms (atrial fibrillation, 13; supraventricular tachycardia, six; rate-sensing lead disruption, four; T wave oversensing, one), and only three as indeterminate rhythms. Based on the electrogram analysis, changes in tachycardia detection criteria and/or antiarrhythmic drug regimens were implemented and were associated with a reduction in the number of device responses for non-VT rhythms from 24 during the initial study period to three during 11.0 +/- 7.2 months of additional follow-up. ICD responses in the absence of symptoms are relatively common in third-generation devices with antitachycardia pacing capabilities. Despite potential limitations such as the effect of bundle branch block on the electrogram morphology during supraventricular tachycardia, the availability of electrogram storage capabilities allowed a presumptive diagnosis of the events precipitating asymptomatic device responses. Device reprogramming based on analysis of stored electrograms was associated with a dramatic reduction in the incidence of ICD responses for non-VT rhythms.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>8504502</pmid><doi>10.1161/01.CIR.87.6.1897</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 1993-06, Vol.87 (6), p.1897-1906
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_75761258
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Atrial Fibrillation - diagnosis
Atrial Fibrillation - epidemiology
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Defibrillators, Implantable
Electrocardiography
Equipment Design
Female
Follow-Up Studies
Heart
Humans
Male
Medical sciences
Middle Aged
Signal Processing, Computer-Assisted
Tachycardia, Supraventricular - diagnosis
Tachycardia, Supraventricular - epidemiology
Tachycardia, Ventricular - diagnosis
Tachycardia, Ventricular - epidemiology
Tachycardia, Ventricular - therapy
Time Factors
title Implantable cardioverter-defibrillator therapy in the absence of significant symptoms : rhythm diagnosis and management aided by stored electrogram analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A48%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implantable%20cardioverter-defibrillator%20therapy%20in%20the%20absence%20of%20significant%20symptoms%20:%20rhythm%20diagnosis%20and%20management%20aided%20by%20stored%20electrogram%20analysis&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=HOOK,%20B.%20G&rft.date=1993-06-01&rft.volume=87&rft.issue=6&rft.spage=1897&rft.epage=1906&rft.pages=1897-1906&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.CIR.87.6.1897&rft_dat=%3Cproquest_cross%3E75761258%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75761258&rft_id=info:pmid/8504502&rfr_iscdi=true